The Beijing-based consultancy Bridge Consulting provides an important reminder that announcements about vaccine deals between China and various African governments are a little bit like many of those MoU announcements that too often fail to deliver real projects.
With vaccines, the key issue is delivery. Bridge reports that Egypt has so far only received 2% of its total order. Until recently, production constraints back in China seem to have been one of the key factors limiting the distribution of vaccines to various countries.